The effect of the Ras homolog gene family (Rho), member A/Rho associated coiled-coil forming protein kinase pathway in atrial fibrosis of type 2 diabetes in rats

Experimental and Therapeutic Medicine

Volumn 8, Issue 3, 2014, Pages 836-840

  Chen, Jinling ^a   Li, Qingqing ^a   Dong, Ruiqing ^a   Gao, Huikuan ^a   Peng, Hui ^a   Wu, Yongquan ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Atrial arrhythmogenicity; Atrial fibrosis; Fasudil; Member A (RhoA) Rho associated coiled coil forming protein kinase pathway; Ras homolog gene family

Indexed keywords

EID: 84904398101     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1843     Document Type: Article

References (21)

1. Kato T, Yamashita T, Sekiguchi A, et al: What are arrhythmogenic substrates in diabetic rat atria? J Cardiovasc Electrophysiol 17: 890-894, 2006.
2. Shimokawa H and Takeshita A: Rho-kinase is an important therapeutic target in cardiovascular medicine. Arterioscler Thromb Vasc Biol 25: 1767-1775, 2005.
3. Shimokawa H: Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases. J Cardiovasc Pharmacol 39: 319-327, 2002.
4. Rolfe BE, Worth NF, World CJ, et al: Rho and vascular disease. Atherosclerosis 183: 1-16, 2005.
5. Tapia PC: RhoA, Rho kinase, JAK2, and STAT3 may be the intracellular determinants of longevity implicated in the progeric influence of obesity: Insulin, IGF-1, and leptin may all conspire to promote stem cell exhaustion. Med Hypotheses 66: 570-576, 2006.
6. Burch ML, Zheng W and Little PJ: Smad linker region phosphorylation in the regulation of extracellular matrix synthesis. Cell Mol Life Sci 68: 97-107, 2011.
7. Hudson VM: Rethinking cystic fibrosis pathology: the critical role of abnormal reduced glutathione (GSH) transport caused by CFTR mutation. Free Radic Biol Med 30: 1440-1461, 2001.
8. Yang L, Dan D, Zhu R, et al: Beta-elemene inhibits expression of ANG II and RhoA/ROCK signaling in hepatic stellate cells. Zhongguo Zhong Yao Za Zhi 34: 458-463, 2009 (In Chinese).
9. Kikuchi Y, Yamada M, Imakiire T, et al: A Rho-kinase inhibitor, fasudil, prevents development of diabetes and nephropathy in insulin-resistant diabetic rats. J Endocrinol 192: 595-603, 2007.
10. Kolavennu V, Zeng L, Peng H, et al: Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control. Diabetes 57: 714-723, 2008.
11. Jiang C, Huang H, Liu J, et al: Fasudil, a rho-kinase inhibitor, attenuates bleomycin-induced pulmonary fibrosis in mice. Int J Mol Sci 13: 8293-8307, 2012.
12. Zhou H, Li YJ, Wang M, et al: Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes. Acta Pharmacol Sin 32: 999-1008, 2011.
13. Gao HC, Zhao H, Zhang WQ, et al: The role of the Rho/Rock signaling pathway in the pathogenesis of acute ischemic myocardial fibrosis in rat models. Exp Ther Med 5: 1123-1128, 2013.
14. Tanaka S, Hayashi T, Toyoda T, et al: High-fat diet impairs the effects of a single bout of endurance exercise on glucose transport and insulin sensitivity in rat skeletal muscle. Metabolism 56: 1719-1728, 2007.
15. Flanagan AM, Brown JL, Santiago CA, et al: High-fat diets promote insulin resistance through cytokine gene expression in growing female rats. J Nutr Biochem 19: 505-513, 2008.
16. Reed MJ, Meszaros K, Entes LJ, et al: A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 49: 1390-1394, 2000.
17. Guan SJ, Ma ZH, Wu YL, et al: Long-term administration of fasudil improves cardiomyopathy in streptozotocin-induced diabetic rats. Food Chem Toxicol 50: 1874-1882, 2012.
18. Wettschureck N and Offermanns S: Rho/Rho-kinase mediated signaling in physiology and pathophysiology. J Mol Med (Berl) 80: 629-638, 2002.
19. Rikitake Y, Kim HH, Huang Z, et al: Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection. Stroke 36: 2251-2257, 2005.
20. Lee DH, Shi J, Jeoung NH, et al: Targeted disruption of ROCK1 causes insulin resistance in vivo. J Biol Chem 284: 11776-11780, 2009.
21. Komers R, Oyama TT, Beard DR, et al: Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure. Kidney Int 79: 432-442, 2011.